Honors and Awards

Studies on adolescent drug abuse, antidepressants in the ER, and complications from heart pumps take top honors at annual seminar

Tue May 14, 2019

Joyce Rifkind (left) and Gary Rifkind, PharmD ’60

Research on topics ranging from drug abuse to heart pump complications took top honors at the Department of Clinical Pharmacy’s 21st annual Spring Research Seminar.

Dong receives Daniel B. Smith Practice Excellence Award for exceptional career

Mon Apr 15, 2019

Betty J. Dong, PharmD ’72, is a world expert on HIV and hepatitis C medication therapy

Dong is a world expert on human immunodeficiency virus (HIV) and hepatitis C medication therapy

Dresser receives Graduate Division Alumnus of the Year Award

Wed Apr 10, 2019

Mark Dresser, Pharmaceutics PhD ’00, Head of Development Sciences at Denali Therapeutics, will receive the 2019 Graduate Division Alumnus of the Year Award during UCSF Alumni Weekend in San Francisco on April 12–13, 2019.

Kortemme and Desai honored at annual meeting of the American Institute for Medical and Biological Engineering

Thu Mar 28, 2019

UCSF Precision Medicine

New and established AIMBE fellows (left to right): Shuvo Roy, PhD, Julius Guccione, PhD, Thomas Link, PhD, Tanja Kortemme, PhD, Atul Butte, PhD, and Tejal Desai, PhD.

School of Pharmacy faculty members Tanja Kortemme and Tejal Desai both received honors at the annual meeting of the American Institute for Medical and Biological Engineering.

2019 Koda-Kimble Seed Award supports School of Pharmacy’s boldest ideas

Tue Mar 12, 2019

Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy

The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.

School of Pharmacy scientists unearth a new target for treating Parkinson’s disease

Thu Mar 7, 2019

Neuronal protein with newly-identified drug target highlighted

England Lab/UCSF

A team led by Pamela England, PhD, identified a new target (yellow) for future Parkinson’s disease therapies within the Nurr1 protein (blue).

Scientists in the UCSF School of Pharmacy recently identified the first drug-binding target site on a molecule known to play a role in Parkinson's disease, opening the door to a new generation of therapies for the condition.

Gift of $500,000 honors Jere E. Goyan, late UCSF School of Pharmacy dean

Tue Feb 12, 2019

UC Regents

Jere E. Goyan, PhD, was the longest-serving dean of the School of Pharmacy and commissioner of the FDA.

The endowment will provide funds for a recipient to focus on delivering breakthroughs in therapeutics-related research, education, and patient care.

Fraser appointed to Bowes Biomedical Investigator Program

Wed Jan 9, 2019

Elisabeth Fall

James Fraser, PhD, developed new ways of doing crystallography over a wide range of temperatures.

Fraser developed several new tools for creating maps of macromolecules, a critical first step for finding new drugs.

Keiser receives $2.5 million to apply machine learning towards new therapies for Alzheimer’s, Parkinson’s

Tue Jan 8, 2019

UCSF

Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will support his research into novel therapies for neurodegeneration.

Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will fund his research into novel therapies for neurodegeneration.

Ortiz de Montellano elected fellow of the Royal Society of Chemistry

Mon Dec 17, 2018

Paul Ortiz de Montellano, PhD, is an expert on P450 enzymes and his latest work looks at their role in tuberculosis infections.

Ortiz de Montellano gained renown for his work with cytochrome P450 enzymes, which help the liver metabolize drugs and other chemicals, and regulate hormone levels.

Categories: Honors and Awards